Tempest Therapeutics, Inc. (TPST) Misses Q3 EPS by 5c

Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q3 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold